(AVTR) Avantor - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US05352A1007
AVTR EPS (Earnings per Share)
AVTR Revenue
AVTR: Lab Supplies, Chemicals, Lab Equipment, Services, Life Sciences
Avantor Inc. is a leading global provider of mission-critical products and services to various industries, including biopharma, healthcare, education, and advanced technologies. The companys extensive portfolio includes a wide range of materials, consumables, equipment, and instrumentation products, as well as specialized services such as scientific research support and biopharmaceutical material scale-up and development.
With a presence in over 30 countries across the Americas, Europe, Asia, the Middle East, and Africa, Avantor serves a diverse customer base, from research institutions to manufacturing facilities. The companys products and services are designed to support the development and production of life sciences and advanced technologies products, including pharmaceuticals, biotechnology products, and medical devices.
From a technical analysis perspective, AVTRs stock price has been trending downward, with the short-term SMA20 at $12.96 and the long-term SMA200 at $19.95, indicating a potential bearish trend. The Average True Range (ATR) of 0.63 represents a 4.86% daily price movement, suggesting moderate volatility. Given the current price of $12.95, a potential support level is seen at the 52-week low of $11.94.
Fundamentally, Avantors market capitalization stands at $8.55 billion, with a price-to-earnings ratio of 12.07 and a forward P/E of 13.07. The companys return on equity is 12.42%, indicating a relatively stable financial performance. Considering the current valuation and growth prospects, a forecast for AVTRs stock price could be made by analyzing the intersection of technical and fundamental data.
Based on the technical indicators and fundamental data, a potential forecast for AVTRs stock price could be a short-term target of $14.50, representing a 12% increase from the current price, driven by a potential reversal of the bearish trend and a return to the SMA50 at $13.96. However, a failure to break above the SMA50 could lead to a continued downward trend, potentially testing the 52-week low of $11.94. Long-term investors may consider a target price of $22.00, representing a 70% increase from the current price, driven by the companys stable financial performance and growth prospects in the life sciences and advanced technologies industries.
Additional Sources for AVTR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
AVTR Stock Overview
Market Cap in USD | 9,247m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC Sub-Industry | Life Sciences Tools & Services |
IPO / Inception | 2019-05-17 |
AVTR Stock Ratings
Growth Rating | -41.5 |
Fundamental | 12.5 |
Dividend Rating | 0.0 |
Rel. Strength | -30.7 |
Analysts | 3.76 of 5 |
Fair Price Momentum | 11.51 USD |
Fair Price DCF | 20.49 USD |
AVTR Dividends
Currently no dividends paidAVTR Growth Ratios
Growth Correlation 3m | -38.8% |
Growth Correlation 12m | -82.6% |
Growth Correlation 5y | -54.5% |
CAGR 5y | -3.89% |
CAGR/Max DD 5y | -0.05 |
Sharpe Ratio 12m | -0.69 |
Alpha | -45.14 |
Beta | 0.421 |
Volatility | 49.06% |
Current Volume | 12831.3k |
Average Volume 20d | 11312.7k |
As of July 01, 2025, the stock is trading at USD 13.53 with a total of 12,831,269 shares traded.
Over the past week, the price has changed by +0.74%, over one month by +3.76%, over three months by -16.53% and over the past year by -34.86%.
Neither. Based on ValueRay´s Fundamental Analyses, Avantor is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 12.50 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of AVTR is around 11.51 USD . This means that AVTR is currently overvalued and has a potential downside of -14.93%.
Avantor has received a consensus analysts rating of 3.76. Therefor, it is recommend to hold AVTR.
- Strong Buy: 6
- Buy: 4
- Hold: 11
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, AVTR Avantor will be worth about 12.5 in July 2026. The stock is currently trading at 13.53. This means that the stock has a potential downside of -7.46%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 17.2 | 26.8% |
Analysts Target Price | 17.2 | 26.8% |
ValueRay Target Price | 12.5 | -7.5% |